表紙
市場調查報告書

抗核抗體 (ANA) 檢驗的全球市場:2017年∼2021年

Global Anti-nuclear Antibody (ANA) Testing Market 2017-2021

出版商 TechNavio (Infiniti Research Ltd.) 商品編碼 507582
出版日期 內容資訊 英文 70 Pages
訂單完成後即時交付
價格
抗核抗體 (ANA) 檢驗的全球市場:2017年∼2021年 Global Anti-nuclear Antibody (ANA) Testing Market 2017-2021
出版日期: 2017年05月24日內容資訊: 英文 70 Pages
簡介

全球抗核抗體 (ANA) 檢驗市場,預計2017年∼2021年以7.13%的年複合成長率成長。

本報告提供全球抗核抗體 (ANA) 檢驗市場相關調查分析,市場規模與成長率,市場趨勢,市場的推動要素與課題,市場機會驗證,主要供應商等相關的系統性資訊。

第1章 摘要整理

第2章 調查範圍

第3章 調查手法

第4章 簡介

第5章 市場形勢

  • 市場概要
  • 市場規模與預測
  • 波特的五力分析

第6章 抗核抗體 (ANA) 檢驗的全球市場:各終端用戶

  • 醫院
  • 臨床診斷研究所

第7章 抗核抗體 (ANA) 檢驗的全球市場:各地區

  • 南北美洲
  • 歐洲、中東、非洲
  • 亞太地區

第8章 決策組成架構

第9章 抗核抗體 (ANA) 檢驗的全球市場:推動因素與課題

第10章 抗核抗體 (ANA) 檢驗的全球市場:趨勢

第11章 業者情勢

  • 競爭模式

第12章 主要供應商分析

  • Abbott Laboratories
  • Alere
  • Bio-Rad Laboratories
  • Thermo Fisher Scientific
  • 其他卓越供應商

第13章 附錄

第14章 關於Technavio

目錄
Product Code: IRTNTR12936

About Anti-Nuclear Antibody (ANA) Testing

Antibodies that attack healthy proteins in the nucleus cells are called antinuclear antibodies. When a person has an autoimmune disease such as rheumatoid arthritis or systemic lupus erythematosus (SLE), the immune system produces antibodies that will attach to the cells, often causing damage to them. Some of the ANA tests are EUROPLUS ANA Mosaic 20A, QUANTA Lite ANA, BioPlex 2200 ANA Screen. The global ANA testing market is expected to benefit from the growing incidence of several autoimmune diseases worldwide.

Technavio's analysts forecast the global anti-nuclear antibody (ANA) testing market to grow at a CAGR of 7.13 % during the period 2017-2021.

Covered in this report

The report covers the present scenario and the growth prospects of the global anti-nuclear antibody (ANA) testing market for 2017-2021. To calculate the market size, the report considers the new installations/sales/volume/value and replacement/ services of anti-nuclear antibody testing market.

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA

Technavio's report, Global Anti-Nuclear Antibody (ANA) Testing Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors

  • Abbott Laboratories
  • Alere
  • Bio-Rad Laboratories
  • Thermo Fisher Scientific

Other Prominent Vendors

  • Antibodies Incorporated
  • Biocom Biotech
  • Erba Diagnostics
  • F. Hoffmann-La Roche
  • HOB Diagnostics
  • HUMAN Diagnostics
  • IMMCO
  • ImmunArray
  • Phadia
  • Seramun Diagnostica
  • Trinity Biotech

Market driver

  • Increased prevalence of autoimmune diseases
  • For a full, detailed list, view our report

Market challenge

  • Limitations of autoimmune disease diagnostics
  • For a full, detailed list, view our report

Market trend

  • Shift from monoplex to multiplex testing
  • For a full, detailed list, view our report

Key questions answered in this report

  • What will the market size be in 2021 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.

Table of Contents

PART 01: Executive summary

PART 02: Scope of the report

PART 03: Research Methodology

PART 04: Introduction

  • Market outline

PART 05: Market landscape

  • Market overview
  • Market size and forecast
  • Five forces analysis

PART 06: Market segmentation by end-user

  • Hospitals
  • Clinical diagnostic laboratories

PART 07: Geographical segmentation

  • ANA testing market in Americas
  • ANA testing market in EMEA
  • ANA testing market in APAC

PART 08: Decision framework

PART 09: Drivers and challenges

  • Market drivers
  • Market challenges

PART 10: Market trends

  • Shift from monoplex to multiplex testing
  • Collaborations between pharma and diagnostic companies
  • Growing consumer shift toward direct-to-consumer testing

PART 11: Vendor landscape

  • Competitive scenario

PART 12: Key vendor analysis

  • Abbott Laboratories
  • Alere
  • Bio-Rad Laboratories
  • Thermo Fisher Scientific
  • Other prominent vendors

PART 13: Appendix

  • List of abbreviations

List of Exhibits

  • Exhibit 01: Etiology of autoimmune diseases
  • Exhibit 02: Global ANA testing market 2016-2021: Market outline
  • Exhibit 03: Key trends in global autoimmune disease diagnostics market: Impact assessment
  • Exhibit 04: Global ANA testing market 2016-2021 ($ millions)
  • Exhibit 05: Five forces analysis
  • Exhibit 06: Global ANA testing market by end-users: Overview
  • Exhibit 07: Global ANA testing market by end-users: Impact assessment
  • Exhibit 08: Global ANA testing market by geography 2016 (%)
  • Exhibit 09: ANA testing market in Americas 2016-2021: Overview
  • Exhibit 10: ANA testing market in Americas 2016-2021 ($ millions)
  • Exhibit 11: ANA testing market in EMEA 2016-2021: Overview
  • Exhibit 12: ANA testing market in EMEA 2016-2021 ($ millions)
  • Exhibit 13: ANA testing market in APAC 2016-2021: Overview
  • Exhibit 14: ANA testing market in APAC 2016-2021 ($ millions)
  • Exhibit 15: Incidence estimates of type 1 diabetes, children aged 0-14 years, 2014
  • Exhibit 16: Key initiatives of vendors fueling the launch of novel biomarkers
  • Exhibit 17: Competitive structure analysis of global ANA testing market 2016
  • Exhibit 18: Competitive landscape analysis of global ANA testing market 2016
  • Exhibit 19: Strategic success factors of companies in global ANA testing market
  • Exhibit 20: Abbott Laboratories: Key highlights
  • Exhibit 21: Abbott Laboratories: Strength assessment
  • Exhibit 22: Abbott Laboratories: Strategy assessment
  • Exhibit 23: Abbott Laboratories: Opportunity assessment
  • Exhibit 24: Alere: Key highlights
  • Exhibit 25: Alere: Strength assessment
  • Exhibit 26: Alere: Strategy assessment
  • Exhibit 27: Alere: Opportunity assessment
  • Exhibit 28: Bio-Rad Laboratories: Key highlights
  • Exhibit 29: Bio-Rad Laboratories: Strength assessment
  • Exhibit 30: Bio-Rad Laboratories: Strategy assessment
  • Exhibit 31: Bio-Rad Laboratories: Opportunity assessment
  • Exhibit 32: Thermo Fisher Scientific: Key highlights
  • Exhibit 33: Thermo Fisher Scientific: Strategy assessment
  • Exhibit 34: Thermo Fisher Scientific: Strategy assessment
  • Exhibit 35: Thermo Fisher Scientific: Opportunity assessment